iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Piramal Pharma Surges 4% as US FDA Issues Positive Report for Bethlehem Facility

9 Nov 2023 , 03:09 PM

Piramal Pharma Ltd’s shares surged nearly 4 % on November 9 following positive action from the US FDA. Piramal Pharma receives an Establishment Inspection Report (EIR) from the US FDA for its manufacturing facility in Bethlehem, USA. The EIR signifies the closure of the inspection, allowing Piramal Pharma to file for drugs from the facility.

The US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma’s Bethlehem facility from September 18 to September 27, 2023. In September, the company received a Form-483 with 2 observations related to system improvement, not data integrity.

Piramal Pharma reports an 11 % YoY increase in consolidated revenue from operations to Rs 1,911 crore in Q2FY24. Consolidated profit after tax (PAT) is Rs 5 crore in the quarter, compared to a loss in the corresponding quarter last fiscal year.

For feedback and suggestions, write to us at editorial@iifl.com

 

 

Related Tags

  • Bethlehem Facility
  • news
  • Piramal Pharma
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.